V251 Pill — BROWN CAPSULE, 25mm — Folic Acid

No photo available
View full Folic Acid profile
ImprintV251
ColourBROWN
ShapeCAPSULE
Size25
StrengthASCORBIC ACID 28 mg;CHOLECALCIFEROL 800 [iU];.ALPHA.-TOCOPHEROL, D- 30 [iU];PYRIDOXINE HYDROCHLORIDE 25 mg;FOLIC ACID 1.25 mg;BIOTIN 250 ug;CALCIUM CARBONATE 158 mg;DOCUSATE CALCIUM 55 mg;FERROUS FUMARATE 29 mg;DOCONEXENT 350 mg
Dosage formCapsule, Gelatin Coated
ManufacturerVirtus Pharmaceuticals OPCO II
NDC76439-251
Schedule—
Availability—
IngredientsASCORBIC ACID[ASCORBIC ACID];CHOLECALCIFEROL[CHOLECALCIFEROL];.ALPHA.-TOCOPHEROL, D-[.ALPHA.-TOCOPHEROL, D-];PYRIDOXINE HYDROCHLORIDE[PYRIDOXINE];FOLIC ACID[FOLIC ACID];BIOTIN[BIOTIN];CALCIUM CARBONATE[CALCIUM CATION];DOCUSATE CALCIUM[DOCUSATE];FERROUS FUMARATE[FERROUS CATION];DOCONEXENT[DOCONEXENT]

What does this imprint mean?

The imprint "V251" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Folic Acid

Uses and warnings

No boxed warning. Key warning: "administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient" - doses above 0.1 mg daily may correct the blood picture while neurologic damage from B12 deficiency continues to progress, so B12 deficiency must be excluded before treating with folic acid alone. The label also notes folic acid may antagonize phenytoin's anticonvulsant action.

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Folic Acid

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file d45e497b-b73c-4774-82d3-3cf51d45a67d.xml